optic nerve glioma (Cancer)
Information
- Disease name
- optic nerve glioma
- Disease ID
- DOID:4992
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02839720 | Completed | Phase 2 | Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma | August 26, 2017 | August 31, 2023 |
| NCT03326388 | Completed | Phase 1/Phase 2 | Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours | September 26, 2019 | February 14, 2024 |
| NCT01837862 | Recruiting | Phase 1/Phase 2 | A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas | October 22, 2013 | April 2025 |
| NCT04648462 | Recruiting | Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology | January 1, 2018 | January 1, 2035 | |
| NCT01260103 | Withdrawn | Phase 3 | Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma | December 2011 | December 2018 |
| NCT02976441 | Withdrawn | Early Phase 1 | Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas | January 2017 | February 2018 |
- Disase is a (Disease Ontology)
- DOID:3419
- Cross Reference ID (Disease Ontology)
- GARD:4107
- Cross Reference ID (Disease Ontology)
- MESH:D020339
- Cross Reference ID (Disease Ontology)
- NCI:C4537
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:254976006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0346326
- Exact Synonym (Disease Ontology)
- glioma of the optic nerve
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0009734
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020339